Dr. Perez-Leal’s research centers on the development of innovative molecular tools to elucidate human disease mechanisms and advance therapeutic discovery. His laboratory has pioneered CRISPR-based genome editing methodologies, emphasizing the creation of sophisticated cellular models for real-time analysis of complex biological processes. A key contribution is the development of the patented FAST-HDR system, a breakthrough technology that enables CRISPR-mediated multiplex gene tagging with fluorescent proteins to generate cellular models for live-cell drug discovery. This platform has been successfully applied to study autophagy, lysosomal storage disorders, and drug toxicity. Currently, his efforts are directed toward refining FAST-HDR to improve its compatibility with induced pluripotent stem cells, thereby facilitating the creation of cellular models that extend beyond the capabilities of conventional laboratory cell lines.
Temple University
Philadelphia, Pennsylvania, USA
Pharmaceutical Sciences
Senior Scientist or Principal Investigator
Temple University, Philadelphia, USA
01 Aug 2017 - present